Cardioprotective Effects of Hydrogen Sulfide and Its Potential Therapeutic Implications in the Amelioration of Duchenne Muscular Dystrophy Cardiomyopathy

被引:2
|
作者
Loboda, Agnieszka [1 ]
Dulak, Jozef [1 ]
机构
[1] Jagiellonian Univ Krakow, Fac Biochem Biophys & Biotechnol, Dept Med Biotechnol, Gronostajowa 7 St, PL-30387 Krakow, Poland
关键词
Duchenne muscular dystrophy; DMD; cardiomyopathy; iPSC-CM; induced pluripotent stem cell-derived cardiomyocytes; hydrogen sulfide; H2S; DOXORUBICIN-INDUCED CARDIOTOXICITY; CONVERTING ENZYME-INHIBITORS; GLUCOSE-INDUCED APOPTOSIS; INDUCED HEART-FAILURE; S-PROPARGYL-CYSTEINE; K-ATP CHANNELS; REPERFUSION INJURY; MYOCARDIAL-INFARCTION; INDUCED INFLAMMATION; CARDIAC DYSFUNCTION;
D O I
10.3390/cells13020158
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Hydrogen sulfide (H2S) belongs to the family of gasotransmitters and can modulate a myriad of biological signaling pathways. Among others, its cardioprotective effects, through antioxidant, anti-inflammatory, anti-fibrotic, and proangiogenic activities, are well-documented in experimental studies. Cardiorespiratory failure, predominantly cardiomyopathy, is a life-threatening complication that is the number one cause of death in patients with Duchenne muscular dystrophy (DMD). Although recent data suggest the role of H2S in ameliorating muscle wasting in murine and Caenorhabditis elegans models of DMD, possible cardioprotective effects have not yet been addressed. In this review, we summarize the current understanding of the role of H2S in animal models of cardiac dysfunctions and cardiac cells. We highlight that DMD may be amenable to H2S supplementation, and we suggest H2S as a possible factor regulating DMD-associated cardiomyopathy.
引用
收藏
页数:30
相关论文
共 50 条
  • [1] Therapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophy
    Ogura, Yuji
    Tajrishi, Marjan M.
    Sato, Shuichi
    Hindi, Sajedah M.
    Kumar, Ashok
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2014, 2
  • [2] Therapeutic potential of adiponectin and adipoRon in Duchenne muscular dystrophy
    Lecompte, S.
    Abou-Samra, M.
    Boursereau, R.
    Noel, L.
    Brichard, S.
    NEUROMUSCULAR DISORDERS, 2015, 25 : S261 - S261
  • [3] Potential therapeutic action of adiponectin in Duchenne muscular dystrophy
    Abou-Samra, M.
    Boursereau, R.
    Noel, L.
    Brichard, S.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S129 - S129
  • [4] Potential Therapeutic Action of Adiponectin in Duchenne Muscular Dystrophy
    Abou-Samra, Michel.
    Boursereau, Raphael
    Lecompte, Sophie
    Noel, Laurence
    Brichard, Sonia M.
    AMERICAN JOURNAL OF PATHOLOGY, 2017, 187 (07): : 1577 - 1585
  • [5] Potential therapeutic targets for hypotension in duchenne muscular dystrophy
    Saxena, Harshi
    Weintraub, Neal L.
    Tang, Yaoliang
    MEDICAL HYPOTHESES, 2024, 185
  • [6] Therapeutic Potential of Immunoproteasome Inhibition in Duchenne Muscular Dystrophy
    Farini, Andrea
    Sitzia, Clementina
    Cassani, Barbara
    Cassinelli, Letizia
    Rigoni, Rosita
    Colleoni, Federica
    Fusco, Nicola
    Gatti, Stefano
    Bella, Pamela
    Villa, Chiara
    Napolitano, Filomena
    Maiavacca, Rita
    Bosari, Silvano
    Villa, Anna
    Torrente, Yvan
    MOLECULAR THERAPY, 2016, 24 (11) : 1898 - 1912
  • [7] Hydrogen sulfide as a therapeutic option for the treatment of Duchenne muscular dystrophy and other muscle-related diseases
    Kazirod, Katarzyna
    Myszka, Malgorzata
    Dulak, Jozef
    Loboda, Agnieszka
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2022, 79 (12)
  • [8] Hydrogen sulfide as a therapeutic option for the treatment of Duchenne muscular dystrophy and other muscle-related diseases
    Katarzyna Kaziród
    Małgorzata Myszka
    Józef Dulak
    Agnieszka Łoboda
    Cellular and Molecular Life Sciences, 2022, 79
  • [9] Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy
    Hong, A. Vu
    Amor, F.
    Corre, G.
    Sanson, M.
    Suel, L.
    Blaie, S.
    Servais, L.
    Voit, T.
    Richard, I.
    Israeli, D.
    NEUROMUSCULAR DISORDERS, 2021, 31 : S74 - S75
  • [10] Targeting RAGE as a potential therapeutic approach to Duchenne muscular dystrophy
    Sagheddu, Roberta
    Chiappalupi, Sara
    Salvadori, Laura
    Riuzzi, Francesca
    Donato, Rosario
    Sorci, Guglielmo
    HUMAN MOLECULAR GENETICS, 2018, 27 (21) : 3734 - 3746